VEEVA SYSTEMS INC VEEV

Veeva AI is a major initiative, making excellent progress in delivering practical, industry-specific solutions. Customers are seeking rapid value beyond experimentation, and Veeva is focused on automating industry applications with deep domain knowledge. The company is accelerating its AI agent roadmap, with agents planned across all software applications by the end of 2026, starting with Commercial this year and expanding to Safety, Quality, Clinical Operations, and Clinical Data Management next year. This integrated approach, combining product, sales, and business consulting, aims to deliver holistic AI value.

Of the top 20 biopharma customers, 14 are expected to migrate to Vault CRM, while 6 are potentially opting for other solutions. Management does not expect a material impact on revenue this fiscal year or next, nor on its 2030 goals, citing the diversity of its business where CRM is now only 20% of total revenue. The company maintains a healthy CRM business with approximately 400 customers beyond the top 20, and sees potential for cross-selling new products like Service Center and marketing automation to retained Vault CRM customers. Win-backs from customers opting for custom-built solutions are possible due to executive turnover or project failures.

Veeva continues to see strong momentum in its R&D Cloud, particularly in eTMF, where all top 20 biopharma customers have selected Veeva. While one customer returned to a competitor for EDC, management views this as an isolated incident, emphasizing the strong pipeline for integrated clinical solutions. Newer areas like RTSM, eCOA, and Safety are still in early adoption phases but show significant promise. The company highlights its competitive advantage in having a unified Development Cloud platform, allowing for shared investments and first-mover advantage since 2012.

Crossix continues to be a strong growth driver, outperforming expectations in Q3 FY26. This performance is attributed to the increasing importance of digital marketing spending in the life sciences industry, both for consumers and healthcare professionals. Crossix's role in measurement, audience targeting, and optimization is becoming more critical as digital channels evolve. The business is expected to sustain strong growth for the foreseeable future, benefiting from significant innovation and investment in its data network, which is shared with Compass.

Veeva is building a unique Industry Cloud for life sciences by integrating software, data, and consulting services. This comprehensive approach positions Veeva as a 'general contractor' for its customers, ensuring seamless integration and long-term compatibility across various solutions. The company's Veeva Basics offering, designed for smaller biotechs, has reached 100 customers and is seen as a critical part of the overall ecosystem, enabling industry growth and providing a scalable solution for emerging companies without requiring system changes as they grow.